Author: cardiopharmagenetadmin

In September 2026, Dr. Adna Ašić, Chair of CardioPharmaGENET, participated in the COST Academy training “Managing International Research Networks” in Brussels, Belgium, representing the Action. The training, delivered by Jan Reinder Rosing, focused on strengthening leadership and management skills essential for coordinating international research networks. Key topics included effective delegation, situational leadership, motivating network members,…

On 1–2 October 2026, Sarajevo hosted the 1st Extended Core Group Meeting of COST Action CardioPharmaGENET (CA24165) at the International University of Sarajevo (IUS), bringing together members of the Action to review achievements from the first Grant Period, define priorities for the next implementation phase, and strengthen scientific collaboration within the international CardioPharmaGENET network. The two-day meeting provided an…

On 17 September 2026, Dr. Theodora Katsila, Science Communication Coordinator and Working Group 5 Leader of CardioPharmaGENET, participated in the COST Academy training “How to Engage with Social Media? – With AI Assistance.” The training focused on strategic and effective science communication across digital platforms, covering audience targeting, platform-specific strategies, social media engagement, and the use of…

Dr. Adna Ašić presented the Action at the MEDICON 2026 Conference, held in Siena, Italy. Bringing cardiovascular pharmacogenomics into a conference strongly focused on biomedical engineering provided an opportunity to introduce CardioPharmaGENET to a broader interdisciplinary community and explore connections between genomics, biomedical engineering, artificial intelligence, medical devices, and regulation. Dr. Ašić delivered two presentations…